Allied Blenders & Distillers Ltd

- Allied Blenders & Distillers do not intend to breach their financial covenants during FY27 despite accelerated capex. - Capex investments will be funded through a combination of internal accruals and borrowing as needed. - There is no mention of any immediate or planned equity fundraising in the provided transcript. - The company maintains disciplined capital allocation and expects leverage metrics to remain within stated guardrails throughout the capex cycle. - Overall, no explicit announcement of new debt or equity fundraising is indicated in the excerpts provided.

- ABD is focused on disciplined execution of strategic, EBITDA-accretive backward integration projects (Page 8). - Setting up a malt plant (12 KLPD) aimed at supporting own malt consumption and launching a single malt within 3 years (Page 17). - PET plant commissioned covering 70-75% of packaging requirements to reduce cost (Page 11). - Planned UP distillery and bottling plant expected in H2 FY27, providing substantial margin leverage including saving ₹27 franchise fee per unit (Page 15). - Capex funded via internal accruals and borrowing without breaching debt covenants (Page 13). - Targeting 300 bps gross margin expansion by FY28 and incremental 100 bps by FY29 through backward integration and price increases (Page 8). - Expansion of ABD Maestro brands with two new brand rollouts and increasing international, travel retail presence (Page 11). - New premium brand launch planned in H2 FY27 (Page 17).

- Company targets mid-teens consolidated top-line growth, supported by strong P&A (Premium & Above) sales growth close to high teens. - ICONiQ White is a key growth driver, already at 12+ million cases, expected to scale further domestically, in CSD channel, and internationally (present in 9 countries). - ABD Maestro portfolio aims to cross ₹100 crore ARR in FY27, with expansion into more states and travel retail. - New product launches planned: Prestige brandy and Prestige vodka targeting a huge 30-40 million case segment; premium brand launch expected in H2 FY27. - OC Blue and Sterling Reserve to stabilize with refreshed A&P efforts and packaging, aiming to arrest decline and bring low single-digit growth. - Premium and above segment volume expected to cross 50%, with value contribution reaching 70-75% over next 3 years. - Long-term aspiration to achieve sustainable profitable growth through premiumization, backward integration, and portfolio expansion.

- Company targets mid-teens consolidated top-line growth, driven by scaling ICONiQ White, arresting de-growth in other millennial brands, and expanding ABD Maestro's super-premium/luxury portfolio. - EBITDA margin guidance: maintain FY26 levels in FY27 despite near-term pressures; expect 18% EBITDA margin by FY28, up 100 bps from earlier 17%. - Gross margin expansion of ~300 bps anticipated by FY28, aided by backward integration, price hikes (e.g., Telangana), and new FTA benefits. - FY27 may see margin pressure in H1 due to geopolitical factors and inflation but expect margin expansion in H2. - Incremental benefits from large CAPEX in PET and distillery units (esp. UP) to be EBITDA accretive. - ABD Maestro portfolio targeting ₹100+ crore ARR in FY27, transitioning from EBITDA negative towards EBITDA neutral by year 3. - Return on capital expected around 25% over next 3 years; EBITDA margin to cross 20% over 3 years with premiumization focus.

The transcript in the provided document does not explicitly mention details on the current or expected order book or pending orders for Allied Blenders & Distillers Limited. However, some relevant growth and expansion initiatives include: - ICONiQ White is growing strongly with billing started in the CSD channel and exports to 9 countries, with expectations for increased international footprint. - ABD Maestro portfolio is expanding with plans to roll out 2 new brands and extend availability from 11 states to more during FY27. - The company is working on launching premium brands, including a “Prestige” vodka and brandy in the medium to long term. - New bottling unit in UP planned to provide margin benefits and support volume growth. - Focus remains on portfolio buildup, distribution expansion, backward integration, and capacity enhancement through capex projects. No direct quantitative order book or pending orders details were disclosed.